BHT (E321)

This is one of the main reasons people search BHT in the first place, but the evidence is not clean. IARC's older evaluation found limited evidence of carcinogenicity in experimental animals and no adequate human data, then placed BHT in Group 3, meaning it is not classifiable as to carcinogenicity in humans. Some rodent studies reported tumor findings, while others did not, and the pattern is less consistent than for BHA. That does not make the concern imaginary; it means current evidence does not justify saying ordinary dietary BHT intake is clearly carcinogenic in humans.

Regulators did not pick BHT intake limits at random. EFSA's 2012 re-evaluation derived an acceptable daily intake of 0.25 mg/kg body weight per day from a no-observed-adverse-effect level in two-generation rat studies, and JECFA's long-standing ADI is 0-0.3 mg/kg/day. The important nuance is dose. These limits were driven mainly by animal toxicology findings at exposures well above what most people get from a single food. So there is a genuine toxicology signal here, but it is better understood as the basis for regulation than as proof that trace dietary exposure is obviously harmful.

This claim is plausible enough to keep studying, but the human evidence is thin. Cell and animal studies have reported estrogenic, anti-estrogenic, thyroid-related, and reproductive effects for BHT or related synthetic phenolic antioxidants, and mixture studies add to that concern. What is missing is strong human evidence showing that food-level exposure to BHT reliably disrupts hormones in real-world diets. The honest reading is that endocrine-disruption language is not baseless, but it is still being inferred mostly from mechanistic and animal data rather than demonstrated clearly in people.

The genotoxicity story is not one-sided. A substantial older review literature found many standard mutagenicity assays for BHT were negative, which is part of why regulators did not classify it as an established human carcinogen. At the same time, some assays, metabolites, and newer mechanistic work keep the question from being fully dismissed. That means the evidence is neither a clean all-clear nor a strong demonstration that normal food exposure causes DNA damage in people. If you see absolute statements either way, they are probably more certain than the literature deserves.

Exposure assessments are more reassuring than the raw toxicology headlines, but they are not meaningless paperwork. EFSA concluded adult exposure from authorised food uses was unlikely to exceed its ADI, while some older intake estimates and recent review papers suggest higher-consuming groups can get closer to, or occasionally exceed, JECFA-style thresholds depending on assumptions and product mix. That does not prove harm in those people; it means dose still matters. Someone eating an occasional cereal bar is in a different exposure category from someone relying heavily on packaged, shelf-stable snack foods every day.

BHT is not a case where regulators around the world have quietly agreed there is no issue. In the US, FDA still permits specified food uses and lists BHT in food-substance inventories and regulations, but on August 19, 2025 the agency added BHT to its updated list of chemicals under post-market review. In Great Britain, the Food Standards Agency still lists E321 as an approved additive, and BHT also remains authorised in the EU with conditions of use. That combination of continued authorization plus renewed scrutiny is a better description than either "totally banned" or "fully settled safe."

For most people, BHT is more a marker of a certain food pattern than a standalone explanation for health outcomes. It tends to show up in shelf-stable snacks, breakfast cereals, fats, chewing gum, and other products where the bigger long-term questions are overall ultra-processed food intake, fiber, energy balance, and what these foods are replacing. Removing one preservative from a diet built around refined, low-fiber packaged foods rarely changes the whole picture much. In LP terms: BHT can be worth limiting if you prefer less additive exposure, but the surrounding diet matters more.